EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Efficacy of single-dose oral dexamethasone versus multidose prednisolone for acute exacerbations of asthma in children aged 2–12 years: A randomized controlled trial

Aishwarya Valli Adinarayanan, Lakshmi Shanmugavel Velmurugan, Senthil Murugan Sivaraman, G. Durai Arasan, Kalpana Sivasambo

Journal of Pediatric Critical Care · 2026-03 · 13 (2) · 73-79

DOI: 10.4103/jpcc.jpcc_109_25 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pediatric Critical Care, online erschienen am 29.04.2026. Verfasst von Aishwarya Valli Adinarayanan und 4 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prednisolone in acute asthma is limited by longer treatment, poor palatability, and vomiting. This study evaluated the efficacy of a single oral dose of dexamethasone compared with a 3-day course of prednisolone in children with acute asthma exacerbations using the Pediatric Respiratory Assessment Measure (PRAM). Subjects and Methods: In this randomized, double-blinded trial, children aged 2–12 years with acute asthma exacerbations were admitted as per hospital protocol. After baseline PRAM scoring, patients were randomized to receive either oral prednisolone (1 mg/kg/day for 3 days) or oral dexamethasone (0.6 mg/kg single dose). Serial PRAM assessments were performed until discharge by a blinded investigator. The primary outcome was time to normalization of PRAM score. The secondary outcomes included vomiting, compliance, persistence of symptoms at day 7, relapse within 14 days, and progression to life-threatening asthma/near-fatal asthma (LTA/NFA).

Results

Of 224 enrolled children, 216 completed follow-up (108 per group). The mean admission PRAM score was 4. The time to normalization was shorter with dexamethasone (2.89 ± 1.05 days; 95% confidence interval [CI]: 2.66–3.12) than prednisolone (3.38 ± 1.15 days; 95% CI: 3.13–3.63; P = 0.0013). Vomiting occurred in 5.6% of prednisolone recipients but in none receiving dexamethasone ( P = 0.013). Progression to LTA/NFA was significantly lower with dexamethasone (16.7% vs. 34.3%; relative risk: 2.676, 95% CI: 1.220–5.871; P = 0.003).

Conclusions

A single oral dose of dexamethasone (0.6 mg/kg) was more effective than a 3-day course of prednisolone (1 mg/kg/day) in reducing asthma severity and significantly lowered the risk of progression to LTA/NFA.

Zitieren

APA

Adinarayanan, A. V., Velmurugan, L. S., Sivaraman, S. M., Arasan, G. D., & Sivasambo, K. (2026). Efficacy of single-dose oral dexamethasone versus multidose prednisolone for acute exacerbations of asthma in children aged 2–12 years: A randomized controlled trial. Journal of Pediatric Critical Care, 13(2), 73-79. https://doi.org/10.4103/jpcc.jpcc_109_25

Vancouver

Adinarayanan AV, Velmurugan LS, Sivaraman SM, Arasan GD, Sivasambo K. Efficacy of single-dose oral dexamethasone versus multidose prednisolone for acute exacerbations of asthma in children aged 2–12 years: A randomized controlled trial. Journal of Pediatric Critical Care. 2026;13(2):73-79. doi:10.4103/jpcc.jpcc_109_25

BibTeX
@article{Adinarayanan2026,
  author = {Adinarayanan, Aishwarya Valli and Velmurugan, Lakshmi Shanmugavel and Sivaraman, Senthil Murugan and Arasan, G. Durai and Sivasambo, Kalpana},
  title = {Efficacy of single-dose oral dexamethasone versus multidose prednisolone for acute exacerbations of asthma in children aged 2–12 years: A randomized controlled trial},
  journal = {Journal of Pediatric Critical Care},
  year = {2026},
  volume = {13},
  number = {2},
  pages = {73--79},
  doi = {10.4103/jpcc.jpcc_109_25}
}
Kostenlos starten →